Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Clasificación en acciones #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Precio por acción
$0.16328419
Capitalización bursátil
$204.14K
Cambio (1 día)
4.35%
Cambio (1 año)
102.45%
País
GB
Comercio Fusion Antibodies plc (FAB)

Categoría

Historial del precio de la acción de Fusion Antibodies plc (FAB)
Precio más alto de cierre: $0.17 el 2026-03-01

Precio más bajo de cierre: $2.40 el 2017-12-01
Historial del precio de la acción de Fusion Antibodies plc desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -21.78%
2025 153.61%
2024 38.42%
2023 -88.93%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$36.82 -51.12%
DK
$451.24 -11.82%
US
$736.53 11.43%
US
$294.88 52.33%
BE
$681.85 12.16%
NL